Holen Sie sich die Stockscreener-App
7.78
1.83%
0.14
Schlusskurs vom Vortag:
$7.64
Offen:
$7.808
24-Stunden-Volumen:
2.09M
Relative Volume:
0.37
Marktkapitalisierung:
$1.32B
Einnahmen:
$1.84M
Nettoeinkommen (Verlust:
$-118.44M
KGV:
-9.3837
EPS:
-0.8291
Netto-Cashflow:
$-98.51M
1W Leistung:
+2.91%
1M Leistung:
-32.87%
6M Leistung:
+160.20%
1J Leistung:
+174.91%
1-Tages-Spanne:
$7.44
$8.14
1-Wochen-Bereich:
$6.692
$8.14
52-Wochen-Spanne:
$2.24
$12.05
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
7.78 | 1.28B | 1.84M | -118.44M | -98.51M | -0.8291 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Absci Corp (ABSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed - marketscreener.com
ABSI|Absci Corp|Price:7.565|Chg%:+0.005 - TradingKey
Absci Corp (ABSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Absci Corp (ABSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
ABSI|Absci Corp|Price:7.726|Chg%:+0.167 - TradingKey
Absci Corp (ABSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ABSI|Absci Corp|Price:7.560|Chg%:-0.510 - TradingKey
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci Corporation (ABSI) Options Chain - Yahoo! Finance Canada
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Siren L.L.C. Takes $5.40 Million Position in Absci Corporation $ABSI - MarketBeat
Absci Corp (ABSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASD - The National Law Review
Wall Street analysts predict a 28.3% upside in ABSCI Corp (ABSI): Here's what you should know - MSN
Absci to report Q2FY26 results on August 11, 2026 - scanx.trade
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 - GlobeNewswire
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know - Yahoo Finance
Wall Street Zen Downgrades Absci (NASDAQ:ABSI) to Sell - MarketBeat
Pre-Market Movement | Absci's Put/Call Ratio Rises - 富途牛牛
Absci director Mary T Szela buys $148,866 in stock - Investing.com
Absci director Mary T Szela buys $148,866 in stock By Investing.com - Investing.com Nigeria
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - 富途牛牛
Form 4 Absci Corp For: 6 July By Investing.com - Investing.com Nigeria
Absci (ABSI) director buys 12,900 shares in open-market trade - Stock Titan
ABSCI CORP (ABSI) soars 36.0%: Is further upside left in the stock? - MSN
ABSI Maintained by Truist Securities -- Price Target Raised to $17.00 - GuruFocus
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $17 - 富途牛牛
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy - Yahoo Finance
BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛
Price to book forward of Absci Corporation – NASDAQ:ABSI - TradingView
AbSci2026 Funding Rounds & List of Investors - Tracxn
Absci Stock (ABSI) Opinions on Positive Phase 1 Data for ABS-201 - Moomoo
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program - Yahoo Finance
Absci (NASDAQ:ABSI) Rating Increased to Hold at Wall Street Zen - MarketBeat
Form 4 Absci Corp For: 26 June By Investing.com - Investing.com Australia
Absci (NASDAQ: ABSI) CEO has 59,896 shares withheld for RSU tax obligation - Stock Titan
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity RaiseHas The Bull Case Changed? - Yahoo Finance
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Absci Corp-Aktie (ABSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pangalos Menelas N | Director |
May 13 '26 |
Buy |
5.36 |
37,453 |
200,748 |
232,308 |
| Busch Andreas | Chief Innovation Officer |
Mar 12 '26 |
Buy |
2.29 |
100,000 |
229,000 |
421,446 |
| Pangalos Menelas N | Director |
Feb 27 '26 |
Buy |
2.74 |
75,095 |
205,760 |
189,055 |
| McClain Sean | Chief Executive Officer |
Feb 23 '26 |
Option Exercise |
1.21 |
396,399 |
479,643 |
8,730,966 |
| McClain Sean | Chief Executive Officer |
Feb 02 '26 |
Sale |
2.99 |
26,761 |
80,015 |
8,334,567 |
| Jonasson Zachariah | CFO / CBO |
Feb 02 '26 |
Sale |
2.99 |
17,496 |
52,313 |
383,538 |
| VAN HOUTEN FRANS | Director |
Dec 05 '25 |
Buy |
3.72 |
40,000 |
148,800 |
63,320 |
| Pangalos Menelas N | Director |
Sep 22 '25 |
Buy |
2.66 |
95,785 |
254,788 |
113,960 |
| Bedrick Todd | SVP, CAO |
Sep 22 '25 |
Buy |
2.70 |
10,000 |
27,000 |
180,428 |
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):